Related Experiment Video
Updated: Aug 13, 2026
10:38
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
Published on: December 17, 2010
Metastatic disease in the pituitary: clinical features
Transactions of the Ophthalmological Societies of the United Kingdom
|January 1, 1982
Summary
Metastatic carcinoma can compress the pituitary gland, causing vision loss and nerve damage. Early diagnosis of these secondary pituitary tumors is crucial for effective preoperative management.
Area of Science:
- Endocrinology
- Neurology
- Oncology
Background:
- Pituitary gland tumors can arise from primary or secondary sources.
- Metastatic lesions to the pituitary are rare but can cause significant neurological deficits.
Observation:
- Reported are three cases of metastatic carcinoma to the pituitary gland.
- These metastases presented with local compression, leading to visual field defects and cranial nerve palsies.
Findings:
- Review of literature on secondary pituitary tumors.
- Discussion on differentiating benign from metastatic pituitary lesions.
- Emphasis on the importance of preoperative diagnosis.
Implications:
- Accurate preoperative diagnosis is vital for appropriate patient management.
- Understanding metastatic patterns to the pituitary aids in clinical suspicion.
- Highlights the need for considering systemic malignancy in pituitary dysfunction.
Related Concept Videos
01:17The Pituitary Gland
The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...